Chaoju Eye Care Holdings Limited disclosed that it bought back 10,000 ordinary shares on 2 April 2026 through on-exchange transactions at HKD 2.72 per share, for a total consideration of HKD 0.03 million.

The repurchased shares are earmarked for cancellation but remained outstanding as of the same date, leaving the issued share capital unchanged at 705.18 million shares.

Under the buy-back mandate granted on 6 June 2025, the company is authorised to repurchase up to 70.75 million shares. Including the latest transaction, cumulative repurchases under this mandate total 2.34 million shares, representing 0.33 % of the issued share count at the mandate date.

A 30-day moratorium on new share issues or treasury share sales applies until 2 May 2026 in accordance with Hong Kong Listing Rules.

The board confirmed that the repurchase complied with all relevant regulatory requirements.